Endologix develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. The company's products are used for the endovascular treatment of abdominal aortic aneurysms (AAA). The company's AAA products are built on one of two platforms: endovascular aneurysm repair (EVAR); and endovascular aneurysm sealing (EVAS), the company's solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The company's EVAR products include the AFX
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.